Close
Back to WLLW Stock Lookup
Pages: 1 2 »» Last Page

(WLLW) –

Aug 31, 2022 07:00 AM WILLOW BIOSCIENCES PROVIDES CBG UPDATE
Aug 15, 2022 07:00 AM WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2022 RESULTS
Jul 18, 2022 07:00 AM WILLOW BIOSCIENCES APPOINTS DR. PETER SEUFER-WASSERTHAL AS INTERIM PRESIDENT AND CEO
Jun 6, 2022 07:00 AM WILLOW BIOSCIENCES INCORPORATES INSCRIPTA'S ONYX® PLATFORM TO EXPAND STRAIN ENGINEERING CAPABILITIES AND THROUGHPUT
May 31, 2022 07:00 AM WILLOW BIOSCIENCES EXPANDS ITS PORTFOLIO WITH A NEW PARTNERED PHARMACEUTICAL PROJECT
May 11, 2022 04:01 PM WILLOW BIOSCIENCES ANNOUNCES EXPANSION OF ITS FERMENTATION MANUFACTURING NETWORK AND PROGRESS ON ITS CBG GRAS DETERMINATION
Jan 31, 2022 07:00 AM WILLOW BIOSCIENCES TO HOST INVESTOR PRESENTATION WEBCAST
Jan 19, 2022 07:00 AM WILLOW BIOSCIENCES PUBLISHES THE FIRST PEER REVIEWED ARTICLE DEMONSTRATING THE CLINICAL BENEFIT OF CBG FOR SKINCARE
Nov 15, 2021 07:00 AM Willow Biosciences Reports Third Quarter 2021 Results
Sep 21, 2021 07:00 AM Willow Biosciences Announces Commercial Scale Operational Update, CBGA Production Update and Corporate Update
Sep 20, 2021 08:35 AM Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
Sep 13, 2021 08:35 AM Willow Biosciences Inc. to Webcast Live at Life Sciences Investor Forum September 16th
Sep 10, 2021 08:35 AM Life Sciences Virtual Investor Conference: Company Executives Present Live September 16th
Jul 20, 2021 07:00 AM Willow Biosciences Announces Expansion of its Commercial Operations Team and Development Portfolio, an Update on its Intellectual Property Position, and Formation of ESG Committee
Jun 10, 2021 07:00 AM Willow Biosciences and Cellular Goods Announce Multiyear Supply Agreement for Cannabigerol (CBG)
May 25, 2021 07:00 AM Willow Biosciences Announces Participation In Synbiobeta Panel Discussion
May 18, 2021 07:00 AM Willow Biosciences Added to NYSE-Listed Cannabis ETF "THCX"
Apr 20, 2021 07:00 AM Willow Biosciences Announces Ground-Breaking Scientific Data for Cannabigerol (CBG) on Human Skin
Mar 31, 2021 07:00 AM Willow Biosciences Announces Completion of its First Commercial Scale Fermentation Run
Feb 19, 2021 11:12 AM Willow Biosciences Announces Exercise of Over-Allotment Option and Completion of Previously Announced Bought Deal Offering
Jan 25, 2021 07:00 AM Willow Biosciences Announces Acceleration of Expiry Date of Outstanding Warrants Issued Pursuant to October 2020 Unit Financing
Jan 19, 2021 07:00 AM Willow Biosciences Advances Its Work On THC; Plans To Launch In The Canadian Market
Jan 13, 2021 07:00 AM Willow Biosciences Provides Update on Cannabigerol Research Studies and Key Personnel Appointment
Dec 16, 2020 07:00 AM Willow Biosciences Advances its Commericalization Plan; First Commercial Production Expected in Early 2021
Nov 19, 2020 05:29 PM Form D Willow Biosciences Inc.
Nov 12, 2020 09:36 PM Willow Biosciences Reports Third Quarter 2020 Results and Operational Update
Oct 8, 2020 06:00 AM Willow Biosciences Partners with Researchers at the University of Lethbridge and University of Calgary to Study Effects Of Non-Psychoactive Cannabinoids on Pain, Inflammation and Depression
Sep 21, 2020 08:35 AM Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
Sep 21, 2020 08:00 AM Willow Biosciences announces successful production of pure cannabigerol
Sep 14, 2020 08:35 AM Virtual Conference for Life Sciences Companies Broadcast Live September 17th, 2020
Sep 14, 2020 08:30 AM Willow Biosciences Inc. to Webcast Live at Life Sciences Investor Forum September 17th   
Jul 22, 2020 07:00 AM OTC Markets Group Welcomes Willow Biosciences Inc. to OTCQX
Jul 10, 2020 08:35 AM Cannabis & CBD Biopharma Investor Presentations Now Available for On-Demand Viewing
Jul 7, 2020 03:00 PM Live Investor Conference & Webinar: Cannabis & CBD Biopharma Industry Companies Present July 9th
Jul 6, 2020 08:35 AM Willow Biosciences Inc. to Webcast Live at VirtualInvestorConferences.com July 9th
Jun 17, 2020 08:00 AM Willow Biosciences Announces Expedited Pilot Production and Adds Multiple New Cannabinoids to Portfolio
May 14, 2020 07:24 PM Willow Biosciences Reports First Quarter 2020 Results And Operational Update
Apr 7, 2020 07:46 PM Willow Biosciences Announces Changes to its Management Team
Mar 24, 2020 09:22 PM Willow Biosciences Reports Fourth Quarter and 2019 Year End Results and Operational Update
Mar 12, 2020 08:00 AM Willow Biosciences Announces Cannabinoid Scale-Up and Expedited Path to Commercialization
Feb 7, 2020 07:30 AM Willow Biosciences Improves Governance with Appointment of Independent Chairman
Dec 3, 2019 05:04 PM Willow Biosciences Announces Trading Date on the Toronto Stock Exchange
Dec 3, 2019 07:30 AM Willow Biosciences Comments on Descheduling of Partner's Cannabidiol by U.S. Drug Enforcement Agency
Nov 25, 2019 08:00 AM Willow Biosciences Receives Conditional Approval to List on the Toronto Stock Exchange
Nov 21, 2019 08:31 PM Willow Biosciences Reports Third Quarter 2019 Results and Provides Operations Update
Nov 7, 2019 07:30 AM Willow Biosciences to Participate in Cowen 2nd Annual Boston Cannabis Conference
Nov 5, 2019 07:30 AM Willow Biosciences to Commence Trading on the OTCQB® Venture Market
Sep 17, 2019 08:30 AM Willow Biosciences to Participate at the Eight Capital & Cassels Brock Global Cannabis Conference
Sep 9, 2019 09:08 PM Willow Biosciences Announces Stock Option Grant and Issuance of Units
Sep 3, 2019 05:56 PM Willow Biosciences Announces Engagement of The Howard Group and Upcoming Presentation at the 8th Annual Gateway Conference on September 5, 2019
Pages: 1 2 »» Last Page

Back to WLLW Stock Lookup